Based on the important roles played by ATAD2 in multiple cancer types, efforts have been focused on developing a new class of potent and specific ATAD2 inhibitors that target its bromodomain, and these inhibitors are currently being tested as therapies for various cancer types [60–62]. Here, ATAD2 is linked to cancer.